Functional Mimicry of the p53 C-terminal Tail by the Ubiquitin-like Molecule SUMO
泛素样分子 SUMO 对 p53 C 末端尾部的功能模拟
基本信息
- 批准号:7614242
- 负责人:
- 金额:$ 17.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-15 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcetylationAffectAlcoholismAmino AcidsAnabolismAnimalsApoptosisBinding ProteinsC-terminalCancer cell lineCancerousCell Cycle ArrestCell Cycle ProgressionCellsChemicalsChimera organismChromatinChromatin Remodeling FactorDNADNA DamageDNA MethylationDNA MethyltransferaseDNA Modification MethylasesDNA biosynthesisDataDependencyDietDietary FactorsDieteticsDioxygenasesDockingEnzymesEpigenetic ProcessEventFeedbackFolateGenesGeneticGrowthHumanIntakeLeadLesionLinkLysineMalignant NeoplasmsMetabolic PathwayMetabolismMethionineMethionine Metabolism PathwayMethylationModificationMolecularMusNamesNatureNutrientOncogene ProteinsOncogenicPathway interactionsPhysiologicalPlayPolyaminesPost-Translational Protein ProcessingPredispositionPreventionPreventivePropertyProtein MethyltransferasesProtein p53ProteinsRattusReactionRecyclingRegulationRoleSeriesSignal TransductionSiteSourceStressSulfurSystemTP53 geneTailTestingTimeTranscriptional RegulationTumor SuppressionTumor Suppressor ProteinsUbiquitinUbiquitin Like ProteinsXenograft procedureYeastsbioactive food componentcell growthchemical groupgenetic regulatory proteininterestmethyl groupmimicryneoplasticneoplastic cellnovelpolypeptidepreventprogramspromoterprotective effectprotein functionpublic health relevancereductoneresponsesenescencestemthree dimensional structuretissue/cell culturetranscription factortransmethylationtumortumor growthtumorigenesis
项目摘要
DESCRIPTION (provided by applicant): The p53 tumor suppressor plays a key role in preventing tumorigenesis. p53 usually responds to various stress signals, and a major recognized trigger for activating p53 in cells is the presence of DNA damage or of DNA-replication stress due to the presence of oncogene products. Once activated, p53 can execute different programs, including senescence, apoptosis and cell cycle arrest. It is well recognized that post-translational modifications affect the ability of p53 to direct cells towards these different cellular programs, depending upon the nature of the signal. In this application we have studied the consequences of a-post-translational modifications of p53, sumoylation. SUMO is a ubiquitin-like molecule which is covalently attached to a variety of target substrates. By conducting these studies we have discovered that sumoylated p53 regulates the expression levels of an enzyme, acireductone dioxygenase, ARD/ADI1 that functions in the methionine salvage pathway. This is a key pathway that regulates the recycling of methionine. One important by-product of this pathway is S-adenosyl methionine (SAM), the major methyl donor for all trans-methylation reactions that involve DNA- and protein-methyltransferases. Interest in this metabolic pathway stems from several observations. First, the majority of cancer cell lines are methionine dependent, and there is evidence that alterations in the MTA pathway account for such dependency. Second, methylthioadenosine (MTA), a product of SAM metabolism, has important effects on DNA replication and cell cycle progression, which are altered in tumor cells. Third, the tumor-predisposing effects of alcoholism, as well as the well-known tumor-protective effects of several dietary factors, such as folates, vitamine B12 and co-balamine, have been linked to the metabolism of methionine. Evidence presented in this application implicate, for the first time, p53 and SUMO as potential modulators of the metabolism of methionine, via ARD/ADI1. Regulation of this pathway could in turn alter susceptibility to dietetic factors, affect SAM levels, and consequently, lead to epigenetic changes that provide a cancer-predisposing milieu. The scope of this exploratory application is the testing of these hypotheses and to understand the molecular mechanisms by which p53 and SUMO regulate the metabolism of methionine. Data gathered with these studies have the potential to identify a novel loop by which the p53 tumor suppressor directly influences cellular responses to nutrients and, thus, cancer predisposition.
PUBLIC HEALTH RELEVANCE: Cancer is the manifestation of a series of abnormal events that involve both genetic and epigenetic changes. Epigenetic changes are achieved via modifications of the activity of proteins that are in intimate contact with the DNA, such as chromatin, and via methylation of the DNA itself. A variety of regulatory proteins that produce such changes, including DNA methyltransferases, methyl-CpG binding proteins, and chromatin remodeling factors, utilize a bio-product of the metabolism of the amino acid methionine, called SAM, for their reactions. It is now well recognized that changes in epigenetic events account for the effects of many environmental and dietetic factors on cancer predisposition. An abnormality of methylation reactions that involve both DNA and proteins is a hallmark of most cancers. We have identified a potential feedback-loop by which a prototypical tumor suppressor, p53, might directly influence cellular responses to nutrients and, thus, cancer predisposition. The general scope of this application is to develop a better understanding of the link between tumor-suppressor pathways, diet, and post-translational modifications that have the potential to influence epigenetic changes.
描述(由申请人提供):p53肿瘤抑制因子在预防肿瘤发生中起关键作用。p53通常响应于各种应激信号,并且在细胞中激活p53的主要公认触发因素是由于癌基因产物的存在而导致的DNA损伤或DNA复制应激的存在。一旦激活,p53可以执行不同的程序,包括衰老,凋亡和细胞周期停滞。众所周知,翻译后修饰影响p53将细胞导向这些不同细胞程序的能力,这取决于信号的性质。在本申请中,我们研究了p53的α-翻译后修饰,sumo化的后果。SUMO是一种与多种靶底物共价结合的泛素样分子。通过进行这些研究,我们已经发现,sumoylated p53调节的表达水平的酶,酸还原酮双加氧酶,ARD/ADI 1的蛋氨酸补救途径的功能。这是调节甲硫氨酸再循环的关键途径。这一途径的一个重要副产物是S-腺苷甲硫氨酸(SAM),它是所有涉及DNA和蛋白质甲基转移酶的甲基转移反应的主要甲基供体。对这一代谢途径的兴趣源于几个观察结果。首先,大多数癌细胞系是甲硫氨酸依赖性的,有证据表明MTA途径的改变导致了这种依赖性。其次,甲基硫代腺苷(MTA),SAM代谢的产物,对DNA复制和细胞周期进程有重要影响,这是在肿瘤细胞中改变。第三,酒精中毒的肿瘤易感性影响,以及众所周知的几种饮食因素,如叶酸,维生素B12和co-balamine的肿瘤保护作用,已与蛋氨酸的代谢有关。本申请中提供的证据首次表明,p53和SUMO通过ARD/ADI 1作为蛋氨酸代谢的潜在调节剂。这一途径的调节可以反过来改变对饮食因素的易感性,影响SAM水平,从而导致表观遗传变化,提供癌症易感环境。这种探索性应用的范围是测试这些假设,并了解p53和SUMO调节蛋氨酸代谢的分子机制。这些研究收集的数据有可能确定一个新的循环,通过这个循环,p53肿瘤抑制因子直接影响细胞对营养物质的反应,从而影响癌症易感性。
癌症是一系列异常事件的表现,涉及遗传和表观遗传变化。表观遗传变化是通过修饰与DNA密切接触的蛋白质(例如染色质)的活性以及通过DNA本身的甲基化来实现的。产生这种变化的各种调节蛋白,包括DNA甲基转移酶、甲基-CpG结合蛋白和染色质重塑因子,利用氨基酸甲硫氨酸代谢的生物产物SAM进行反应。现在人们已经认识到,表观遗传事件的变化可以解释许多环境和饮食因素对癌症易感性的影响。涉及DNA和蛋白质的甲基化反应异常是大多数癌症的标志。我们已经确定了一个潜在的反馈回路,通过这个回路,一个典型的肿瘤抑制因子p53可能直接影响细胞对营养物质的反应,从而影响癌症易感性。本申请的一般范围是更好地理解肿瘤抑制途径、饮食和翻译后修饰之间的联系,这些修饰有可能影响表观遗传变化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARIA L AVANTAGGIATI其他文献
MARIA L AVANTAGGIATI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARIA L AVANTAGGIATI', 18)}}的其他基金
Targeting the metabolic vulnerabilities of patient-derived drug resistant tumors
针对患者来源的耐药肿瘤的代谢脆弱性
- 批准号:
10311106 - 财政年份:2020
- 资助金额:
$ 17.27万 - 项目类别:
Role of the mitochondrial citrate carrier SLC25A1(CIC)in cancer progression and therapy
线粒体柠檬酸载体SLC25A1(CIC)在癌症进展和治疗中的作用
- 批准号:
8859263 - 财政年份:2015
- 资助金额:
$ 17.27万 - 项目类别:
Role of the mitochondrial citrate carrier SLC25A1(CIC)in cancer progression and therapy
线粒体柠檬酸载体SLC25A1(CIC)在癌症进展和治疗中的作用
- 批准号:
9235268 - 财政年份:2015
- 资助金额:
$ 17.27万 - 项目类别:
Functional Mimicry of the p53 C-terminal Tail by the Ubiquitin-like Molecule SUMO
泛素样分子 SUMO 对 p53 C 末端尾部的功能模拟
- 批准号:
7479043 - 财政年份:2008
- 资助金额:
$ 17.27万 - 项目类别:
Role of the Acetyltransferase p300 in Cellular Responses
乙酰转移酶 p300 在细胞反应中的作用
- 批准号:
6640927 - 财政年份:2002
- 资助金额:
$ 17.27万 - 项目类别:
相似海外基金
Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
- 批准号:
EP/Y000331/1 - 财政年份:2023
- 资助金额:
$ 17.27万 - 项目类别:
Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
- 批准号:
10677295 - 财政年份:2023
- 资助金额:
$ 17.27万 - 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
- 批准号:
10635599 - 财政年份:2023
- 资助金额:
$ 17.27万 - 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
- 批准号:
10752320 - 财政年份:2023
- 资助金额:
$ 17.27万 - 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
- 批准号:
478927 - 财政年份:2023
- 资助金额:
$ 17.27万 - 项目类别:
Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
- 批准号:
10855703 - 财政年份:2023
- 资助金额:
$ 17.27万 - 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
- 批准号:
10654210 - 财政年份:2023
- 资助金额:
$ 17.27万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 17.27万 - 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
- 批准号:
10667952 - 财政年份:2023
- 资助金额:
$ 17.27万 - 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
- 批准号:
10726986 - 财政年份:2023
- 资助金额:
$ 17.27万 - 项目类别: